[1]
Petrova, G. et al. 2024. BIOSIMILAR MEDICINAL PRODUCTS – LEGISLATIVE DECISIONS AND MARKET ENTRY. Rheumatology (Bulgaria). 32, 1 (Nov. 2024), 45–56. DOI:https://doi.org/10.35465/32.1.2024.pp45-56.